Aptargroup

ATR · NYSE

$125.77+$1.14 (+0.91%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $124.63

Latest news

Press releaseOct 14, 5:00 PM ETBusiness Wire
Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers
Press releaseSep 14, 5:00 PM ETBusiness Wire
Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
NewsJul 30, 5:05 PM ET
AptarGroup Q2 Adj. EPS $1.42 Beats $1.35 Estimate, Sales $1.027B Beat $1.008B Estimate
Press releaseJul 30, 5:00 PM ETBusiness Wire
Aptar Reports Second Quarter 2026 Results
Press releaseJul 27, 5:00 PM ETBusiness Wire
Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year
Press releaseJul 20, 5:00 PM ETBusiness Wire
Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare Dosing
Press releaseJul 16, 5:00 PM ETBusiness Wire
Aptar Declares Quarterly Dividend
Press releaseJul 13, 5:00 PM ETBusiness Wire
Aptar Named Among Top 100 of America’s Best Companies by TIME
Press releaseJun 18, 5:00 PM ETBusiness Wire
Aptar Releases 2025 Corporate Sustainability Report
Press releaseJun 2, 5:00 PM ETBusiness Wire
Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year
Press releaseMay 27, 5:00 PM ETBusiness Wire
Aptar to Participate in Upcoming Investor Conferences
Press releaseMay 6, 5:00 PM ETBusiness Wire
Aptar Advances Sustainability Features in Luxury Packaging through Patented Reloadable Airless Innovation with Clarins
NewsMay 1, 9:55 AM ET
Full Transcript: AptarGroup Q1 2026 Earnings Call
NewsApr 30, 5:01 PM ET
AptarGroup Q1 Adj. EPS $1.19 Beats $1.15 Estimate, Sales $982.868M Beat $955.283M Estimate
Press releaseApr 30, 5:00 PM ETBusiness Wire
Aptar Reports First Quarter 2026 Results
NewsApr 30, 7:11 AM ET
Earnings Scheduled For April 30, 2026
Press releaseApr 27, 5:09 PM ETBusiness Wire
Aptar Turns Beauty and Personal Care Products Upside Down with Inverted Lidless Dispensing Closures for Clean, Single‑Handed Dispensing
Press releaseApr 23, 5:00 PM ETBusiness Wire
Aptar Declares Quarterly Dividend
Press releaseApr 22, 5:00 PM ETBusiness Wire
Aptar Recognized as One of America's Climate Leaders by USA Today for the Fourth Consecutive Year
Press releaseApr 8, 4:00 PM ETBusiness Wire
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
Press releaseMar 19, 5:00 PM ETBusiness Wire
Aptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray
Press releaseMar 17, 5:00 PM ETBusiness Wire
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year
Press releaseMar 16, 5:00 PM ETBusiness Wire
Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray
NewsFeb 26, 8:56 AM ETAvi Kapoor
Top 2 Consumer Stocks You May Want To Dump This Quarter
Press releaseFeb 18, 5:00 PM ETBusiness Wire
Aptar to Participate in Upcoming Investor Conferences
NewsFeb 5, 5:02 PM ET
AptarGroup Sees Q1 Adj EPS $1.13-$1.21 vs $1.15 Est
NewsFeb 5, 5:01 PM ET
AptarGroup Q4 Adj. EPS $1.25 Beats $1.23 Estimate, Sales $962.736M Beat $882.208M Estimate
Press releaseFeb 5, 5:00 PM ETBusiness Wire
Aptar Reports Fourth Quarter and Annual 2025 Results
NewsFeb 5, 6:11 AM ET
Earnings Scheduled For February 5, 2026
Press releaseJan 22, 5:00 PM ETBusiness Wire
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details
Press releaseJan 21, 5:00 PM ETBusiness Wire
Aptar Again Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment
Press releaseJan 13, 5:00 PM ETBusiness Wire
Aptar's Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate
Press releaseJan 12, 5:00 PM ETBusiness Wire
Aptar's Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
Press releaseOct 30, 5:00 PM ETBusiness Wire
Aptar Reports Third Quarter 2025 Results
NewsSep 24, 8:22 AM ETAvi Kapoor
Top 3 Materials Stocks That May Rocket Higher In Q3
NewsSep 8, 5:03 PM ET
AptarGroup Increases Its Quarterly Dividend From $0.45 To $0.48
Press releaseSep 8, 5:00 PM ETBusiness Wire
Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength
NewsSep 4, 10:14 AM ETAvi Kapoor
This HubSpot Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Press releaseJul 31, 5:00 PM ETBusiness Wire
Aptar Reports Second Quarter 2025 Results
NewsJul 30, 12:01 PM ET
What to Expect from AptarGroup's Earnings
NewsFeb 22, 9:00 AM ETChris Katje
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
NewsFeb 7, 1:27 PM ETPiero Cingari
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?
NewsJan 10, 8:58 AM ETAvi Kapoor
Top 3 Materials Stocks That Are Set To Fly This Month

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

AptarGroup Q2 Adj. EPS $1.42 Beats $1.35 Estimate, Sales $1.027B Beat $1.008B Estimate

Aptar Reports Second Quarter 2026 Results

Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year

Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare Dosing

Aptar Declares Quarterly Dividend

Aptar Named Among Top 100 of America’s Best Companies by TIME

Aptar Releases 2025 Corporate Sustainability Report

Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year

Aptar to Participate in Upcoming Investor Conferences

Aptar Advances Sustainability Features in Luxury Packaging through Patented Reloadable Airless Innovation with Clarins

Full Transcript: AptarGroup Q1 2026 Earnings Call

AptarGroup Q1 Adj. EPS $1.19 Beats $1.15 Estimate, Sales $982.868M Beat $955.283M Estimate

Aptar Reports First Quarter 2026 Results

Earnings Scheduled For April 30, 2026

Aptar Turns Beauty and Personal Care Products Upside Down with Inverted Lidless Dispensing Closures for Clean, Single‑Handed Dispensing

Aptar Declares Quarterly Dividend

Aptar Recognized as One of America's Climate Leaders by USA Today for the Fourth Consecutive Year

Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

Aptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray

Top 2 Consumer Stocks You May Want To Dump This Quarter

Aptar to Participate in Upcoming Investor Conferences

AptarGroup Sees Q1 Adj EPS $1.13-$1.21 vs $1.15 Est

AptarGroup Q4 Adj. EPS $1.25 Beats $1.23 Estimate, Sales $962.736M Beat $882.208M Estimate

Aptar Reports Fourth Quarter and Annual 2025 Results

Earnings Scheduled For February 5, 2026

Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

Aptar Again Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment

Aptar's Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate

Aptar's Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™

Aptar Reports Third Quarter 2025 Results

Top 3 Materials Stocks That May Rocket Higher In Q3

AptarGroup Increases Its Quarterly Dividend From $0.45 To $0.48

Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength

This HubSpot Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Aptar Reports Second Quarter 2025 Results

What to Expect from AptarGroup's Earnings

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?

Top 3 Materials Stocks That Are Set To Fly This Month